Global Health Matters

13 November 2020 - By Cary Adams
For World Antimicrobial Awareness Week (WAAW), Dr Cary Adams shares with us the importance of raising awareness on the growing threat of antimicrobial resistance and how it affects the cancer community. In what circumstances and how often are antibiotics used for cancer treatment and care? The treatment and care of ...
Read More
6 November 2020 - By Thomas B. Cueni
Dame Sally Davies, UK AMR Special Envoy and Thomas Cueni, IFPMA’s DG have shared platforms on panels.  This time at the World AMR Congress, saw the duo in a different format, with Dame Sally pitching questions at Thomas Cueni and asking him if industry has done enough to tackle AMR.  ...
Read More
26 October 2020 - By Thomas B. Cueni
Watch full interview hereThomas Cueni, IFPMA Director General, spoke to Al Jazeera English, on the side lines of the World Health Summit, about collaboration between the pharmaceutical industry and governments to make sure COVID 19 vaccines are available in poorer countries; as well as industry’s commitment to the most rigorous ...
Read More
19 October 2020 - By Thomas B. Cueni
On Saturday October 17, I was honoured to take part in the 8th edition of the African Invention and Technological Innovation Fair organized by the Organisation Africaine sur la Propriété Intellectuelle (OAPI). Innovation, creativity and intellectual property are linked to socio-economic development. The African Invention and Technology Innovation Fair plays ...
Read More
13 October 2020 - By
Since the beginning of the COVID-19 crisis, innovative players and industries operating in the health sector have been pressed to collaborate, innovate, and accelerate their research and development efforts in response to these unprecedented times.  The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), the trade association that represents biopharmaceutical ...
Read More
9 October 2020 - By Wendy Orchard
In the lead up to World Mental Health Day we sat down with Wendy Orchard, Executive Director of the International Association for Suicide Prevention (IASP) as she prepares to hold a virtual March for mental health, to find out what has been the impact of COVID-19 on mental health and ...
Read More
5 October 2020 - By Eric de Roodenbeke
Hospitals have been at the forefront in fighting the COVID-19 pandemic. We sat down with Eric de Roodenbeke, CEO of the International Hospital Federation to talk about how hospitals have adapted to the new normal as we continue to grapple with the pandemic. 5 Questions to … Eric de Roodenbeke ...
Read More
25 September 2020 - By Thomas B. Cueni
I recently participated in Chatham House Webinar: Creating a New Generation of Antibiotics. It was a great opportunity for me to tell Jim O’ Neill, how little over a year ago, he played a role in speeding up industry action on AMR - something I had decided the IFPMA should ...
Read More
18 September 2020 - By Thomas B. Cueni
Thomas Cueni, IFPMA Director General, spoke to BBC World Service Marketplace Morning Report about the efforts and challenges to produce and deliver a vaccine for COVID-19 Victoria Craig One of the keys to getting economies back to some form of normalcy is a vaccine. The US said that it could ...
Read More
18 September 2020 - By Thomas B. Cueni
Interview - Asahi TV Japan - Solidarity at the core of COVAX Facility Thomas Cueni, IFPMA Director General, spoke to Asahi TV in Japan on 18 September 2020 about COVAX and the importance of working together in order to guarantee a safe and effective vaccine in both richer and poorer ...
Read More
17 September 2020 - By Thomas B. Cueni
The biopharmaceutical industry has made addressing the pandemic its top priority, devoting its resources, expertise, know-how, and intellectual assets to developing potential treatments and vaccines at record speed, while committing to and engaging in unprecedented levels of international collaboration and coordination through initiatives such as ACT-A, ACTIV and CEPI to ensure equitable access to products being developed. ...
Read More
17 September 2020 - By Thomas B. Cueni
Today I had the pleasure to participate in The New World Model, an online event on the future of industry, organised by the World Free Zones Organization. The event seeks to explore the different angles of the new industry business models likely to emerge in a post-pandemic landscape. I was ...
Read More
17 September 2020 - By Thomas B. Cueni
This article first appeared in the Global Cause on the Infectious Diseases campaign. A printed publication was enclosed within every copy of New Scientist magazine and the content is available online on the Global Cause website. The campaign featured exclusive content from key thought leaders and industry voices about pharmaceutical ...
Read More
14 September 2020 - By Thomas B. Cueni
On 3rd September, CEOs from five companies – Pfizer, Roche, MSD, Gilead, and Lilly took part in the latest IFPMA COVID-19 virtual media briefing dedicated to the on-going efforts to find a treatment for COVID-19. During the course of the pandemic, we have witnessed a remarkable show of solidarity, partnership, ...
Read More
9 September 2020 - By James Headen Pfitzer
With more than 20 IFPMA member companies, Access Accelerated is the largest collective industry effort to address inequities in non-communicable disease care. Access Accelerated recently launched its Year 3 report, chronicling the initiative’s collective efforts in 2019 to advance access to NCD prevention, treatment and care in low- and middle-income ...
Read More
1 2 3 12